{"id":"W3035452648","doi":"10.1016/s2213-8587(20)30187-x","title":"Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials","year":2020,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Boehringer Ingelheim; Novo Nordisk; Abbott Laboratories; Sanofi; Merck; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company","keywords":"Canagliflozin; Dapagliflozin; Empagliflozin; Medicine; Type 2 diabetes; Drug class; Diabetes mellitus; Clinical trial; Internal medicine; Glycemic; Pharmacology; Intensive care medicine; Endocrinology; Drug","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05904769,0.0007500927,0.003149428,0.004100759,0.001215738,0.007745103,0.003539525,0.01641809,0.006921616],"category_scores_gemma":[0.3225507,0.0011221,0.002252099,0.007709529,0.002667977,0.006313581,0.003591537,0.01445069,0.005354024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002564825,"about_ca_system_score_gemma":0.005287392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004210899,"about_ca_topic_score_gemma":0.01027926,"domain_scores_codex":[0.9357943,0.03916681,0.01260092,0.00215773,0.008696089,0.001584088],"domain_scores_gemma":[0.3807335,0.5317803,0.03379165,0.0161788,0.03159817,0.00591765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.003078898,0.0001846353,0.06252976,0.002922807,0.002349489,0.001526465,0.0005150699,0.0002439721,0.0002440231,0.006464849,0.8045955,0.1153445],"study_design_scores_gemma":[0.008650255,0.0009783974,0.1251978,0.02100277,0.00523513,0.003588595,0.001860183,0.002107942,0.0008065396,0.08280534,0.7472499,0.0005170744],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.008352278,0.0233184,0.0006991759,0.9376388,0.01407481,0.00005546326,0.006877617,0.00006784052,0.008915555],"genre_scores_gemma":[0.0692882,0.01812087,0.003595766,0.8349221,0.0660865,0.0002603458,0.004874192,0.0001150285,0.002737002],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05904769,"threshold_uncertainty_score":0.3122777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2355105623545768,"score_gpt":0.3721536130965929,"score_spread":0.136643050742016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}